Literature DB >> 34772606

G-CSF, the guardian of granulopoiesis.

Hrishikesh M Mehta1, Seth J Corey2.   

Abstract

A considerable amount of continuous proliferation and differentiation is required to produce daily a billion new neutrophils in an adult human. Of the few cytokines and factors known to control neutrophil production, G-CSF is the guardian of granulopoiesis. G-CSF/CSF3R signaling involves the recruitment of non-receptor protein tyrosine kinases and their dependent signaling pathways of serine/threonine kinases, tyrosine phosphatases, and lipid second messengers. These pathways converge to activate the families of STAT and C/EBP transcription factors. CSF3R mutations are associated with human disorders of neutrophil production, including severe congenital neutropenia, neutrophilia, and myeloid malignancies. More than three decades after their identification, cloning, and characterization of G-CSF and G-CSF receptor, fundamental questions remain about their physiology.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CSF3R; G-CSF; G-CSFR; GCSF; Granulocytes; Granulopoiesis; MDSC; Neutrophils

Mesh:

Substances:

Year:  2021        PMID: 34772606     DOI: 10.1016/j.smim.2021.101515

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  3 in total

Review 1.  Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management.

Authors:  Thomas P Thomopoulos; Argiris Symeonidis; Alexandra Kourakli; Sotirios G Papageorgiou; Vasiliki Pappa
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

2.  Suppression of Aspergillus fumigatus Germination by Neutrophils Is Enhanced by Endothelial-Derived CSF3 Production.

Authors:  Wenxin Zhang; Dan He; Yunyun Wei; Shumi Shang; Dong Li; Li Wang
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

3.  Bioinformatics analysis of potential pathogenesis and risk genes of immunoinflammation-promoted renal injury in severe COVID-19.

Authors:  Zhimin Chen; Caiming Chen; Fengbin Chen; Ruilong Lan; Guo Lin; Yanfang Xu
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.